SRCIN1 and non-small cell lung carcinoma: Our findings provided a new viewpoint into the posttranscriptional regulation mechanism of SRCIN1 and suggested that circCCDC66, SRCIN1, and miR-211 might act as a potential diagnostic biomarker for NSCLC.